Published in
BioMed Central, Arthritis Research and Therapy, 1(21), 2019
DOI: 10.1186/s13075-019-1917-8
Links
Tools
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
Journal article published in 2019 by
Denis Choquette 
,
Louis Bessette,
Evo Alemao,
Boulos Haraoui,
Roelien Postema,
Jean-Pierre Raynauld,
Louis Coupal
,
Louis Bessette,
Evo Alemao,
Boulos Haraoui,
Roelien Postema,
Jean-Pierre Raynauld,
Louis Coupal
This paper is made freely available by the publisher.
Full text: Download
Data provided by 